Infection Surveillance Solutions Market

Updated on : February 16, 2023

The global infection surveillance solutions market in terms of revenue was estimated to be worth $577 million in 2022 and is poised to reach $1,100 million by 2027, growing at a CAGR of 13.8% from 2022 to 2027.

The market growth is primarily driven by the rising number of hospital-acquired infections (HAIs) and new Medicare policies that include non-payment for hospital-acquired conditions. Additionally, factors such as increased healthcare spending, growing number of surgeries, growing aging population, and increasing prevalence of chronic diseases are also contributing to the market growth. On the other hand, the high cost of health IT solutions deployment in small healthcare organizations especially in developing countries and the reluctance among medical professionals to adopt advanced healthcare IT solutions are likely to hinder the growth of this market during the forecast period.

Attractive Opportunities in the Global Infection Surveillance Solutions Market

To know about the assumptions considered for the study, Request for Free Sample Report

Recession Impact on Global Infection Surveillance Solutions Market

A recession is a temporary economic decline during which trade and industrial activities are reduced. It is generally identified by a decline in the GDP in two successive quarters. According to the International Monetary Fund’s World Economic Outlook Report (October 2022), global GDP growth would slow from 6.0% in 2021 to 3.2% in 2022 and 2.7% in 2023. Similarly, global inflation would rise from 4.7% in 2021 to 8.8% in 2022 but decline to 6.5% in 2023 and 4.1% by 2024.

The key reasons behind this slowdown are the rising global inflation and the Russia-Ukraine war, which led to a severe energy crisis in Europe, where gas prices have escalated fourfold since 2021. Frequent lockdowns in China under its ‘Zero COVID policy’ led to a weakened economy, which, in turn, impacted global trade and led to a sharp appreciation of the US dollar.

The covid-19 pandemic forced governments to spend heavily on rolling out vaccination programs and investing in healthcare infrastructure and staffing. However, government plans to maintain or increase spending to tackle a backlog of non-COVID care and resolve staffing issues have been upended by the global economic slowdown. The Economist Intelligence Unit expects total healthcare spending (public and private combined) to rise by 4.9% in nominal terms in 2023, propelled by higher costs and wages. However, spending is expected to decline slightly in real terms as it may fail to keep pace with inflation.

Healthcare digitization efforts will continue, but the use of health data is expected to come under stricter regulation in the US, Europe, and China. The demand for infection surveillance solutions is expected to fall slightly, and the recession will have a low-to-moderate impact on healthcare-oriented businesses. Macroindicators such as inflation and supply chain disruptions might temporarily affect the demand for infection surveillance solutions. High prices of infection surveillance solutions due to inflation will affect the demand in the short run. But in the long run, the demand is expected to become normal.

Infection Surveillance Solutions Market Dynamics

Drivers: Increasing adoption of antimicrobial stewardship programs

Infection Control and Epidemiology (APIC) are focusing on curbing the increasing incidence of HAIs.

Antimicrobial resistance (AMR) is a global health and development threat. The WHO declared AMR one of the top 10 global public health threats facing humanity. According to the WHO 2020 report, the cost of AMR to the global economy is significant. In addition to death and disability, prolonged illness results in longer hospital stay, the need for more expensive medicines, and financial challenges for those impacted. In 2015, the WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS), which incorporates data from the surveillance of AMR in humans and surveillance of antimicrobial medicine use. GLASS provides a standardized approach to collecting, analyzing, interpreting, and sharing data by countries, territories, and areas and monitors the status of existing and new national surveillance systems. Various market players such Wolters Kluwer N.V. (Netherlands), Vecna Technologies, Inc. (US), bioMerieux SA (France) among others as have created surveillance solutions for antimicrobial stewardship to cater to the needs of healthcare facilities.

Restraints: High cost of deployment for small healthcare organizations

Implementing healthcare IT software solutions is costly due to the high cost of interoperability and deployment. Smaller healthcare organizations face challenges in implementing internet connectivity, which results from difficulties in setting up multiple networks in healthcare environments, limited wireless options, and the need for extensive security measures to prevent data breaches. Additionally, infection surveillance software is expensive. Moreover, support and maintenance services, which include modification and upgrading software as per the changing user requirements, represent a recurring expenditure that accounts for a large share of the total cost of ownership. Furthermore, custom interface development for device integration post-sales requires extra validation and verification, adding to the total cost of ownership for healthcare providers. These additional costs are unaffordable for smaller hospitals and healthcare organizations.

Opportunities: Emerging Markets

The infection surveillance solutions market is expected to experience significant growth opportunities in countries with emerging economies such as India, China, Brazil, Russia, and countries in Latin America and Southeast Asia. This is due to the fact that these regions are home to a large portion of the world's population, with over half residing in India and China. Additionally, factors such as public demand for better quality hospital care, the rise in costs associated with healthcare-associated infections (HAIs), the emergence of multi-drug-resistant microorganisms, and government initiatives are contributing to the growth of the market in these countries.

With the growth in per capita income, increasing healthcare awareness, a growing number of hospitals and clinics, and a vast patient population, the demand for better healthcare services has increased in these countries. Also, emerging economies in the APAC present lucrative investment opportunities for multinational healthcare IT companies to offshore their business operations to these markets. Expansions in emerging markets are driving the adoption of infection control technologies in the medical device manufacturing industry in these countries, thereby providing opportunities for market growth.

Challenges: Data security concerns

The growing reliance on networking and automated technologies (EHR) and the shifting trend toward healthcare integration and health information exchanges have helped expand the healthcare privacy and security landscape. The electronic exchange of patient data offers greater reach and efficiency in healthcare delivery; however, issues related to data loss and liability due to broader access are associated with the electronic exchange of patient data.

Wide patient information exchanges lead to privacy and security risks and increase the chances of data breaches. In healthcare, approximately one-third of data breaches result in medical identity theft, mainly due to a lack of internal control over patient information, outdated policies, procedures (or nonadherence to existing ones), and inadequate personnel training. In the US, the Identity Theft Resource Center reported that the healthcare industry had the second-largest number of data breaches in 2019, along with the highest exposure rate per breach.

Data collected from various sources are transferred or directly entered into infection surveillance platforms. Creating a secure communication platform is a major challenge faced by healthcare IT vendors catering to the healthcare industry. Potential security concerns related to HCIT systems in healthcare organizations may lead to a sense of insecurity among users, restraining the adoption of HCIT solutions, including infection surveillance solutions, across the globe.

Infection Surveillance Solutions Market: Ecosystem Analysis

The infection surveillance service segment, by product & service, is expected to witness the fastest growth, in infection surveillance solutions market, during forecast period

Based on product, the market is segmented into infection surveillance software solutions and infection surveillance services. In 2021, the infection surveillance software segment is expected to be witness fastest growth during the forecast period. Growth in the infection surveillance services market is mainly driven by the increasing importance of infection surveillance in the healthcare industry. Moreover, the growing need to ensure effective HAI management and reduce the burden of HAI-related complications is expected to play a major role in the growth of the infection surveillance services market during the forecast period.

By type, the on-premise software segment accounted for the largest share of the infection surveillance solutions market during forecast period

The on-premise software segment dominated the market during the forecast period, accounting for the largest share. This can be attributed to the requirement for secure access to healthcare IT solutions and the need to minimize the risk of data breaches and external attacks. As a result, many healthcare organizations prefer on-premise software solutions to ensure that their confidential information is kept secure. Another benefit, specifically for organizations migrating or upgrading from one system to another, is the possibility of reusing existing servers and storage hardware.

The product support and maintenance services segment accounted for the largest share of the infection surveillance solutions market, by type, in 2021

In 2021, the product support and maintenance services segment dominated the market owing to the requirement for continuous product updates and technical support for infection surveillance software. The growth of the product support and maintenance services segment is driven by the need for clients (healthcare providers) to access the technical knowledge base of the vendor company, receive support from its product support team, and develop application management skills. These services help ensure that healthcare providers are able to effectively use and manage their infection surveillance software, resulting in improved outcomes and increased efficiency. By offering these services, vendor companies can provide ongoing value to their clients and enhance customer satisfaction.

North America is expected to be the largest and fastest market segment in the global infection surveillance solutions market during the forecast period

North America is expected to dominate the global market between 2022–2027, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market in North America is witnessing significant developments owing to factors such as the widespread adoption of healthcare IT solutions to curtail the escalating healthcare costs, growing consolidation among healthcare providers, and increasing incidence of HAIs in the US. The presence of a large number of players in the region is also a key factor contributing to the large share of North America in the infection surveillance solutions market.

To know about the assumptions considered for the study, download the pdf brochure

The prominent players in the infection surveillance solutions market include Becton, Dickinson and Company (US), Premier, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Clinisys (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), Merative (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab (US), Harris Healthcare (US), PeraHealth (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and VIZZIA Technologies (US). Between 2020 and 2023, the companies adopted growth strategies such as product launches/enhancements, expansions, agreements, partnerships, collaborations, sales contracts, investments, joint ventures, and acquisitions to capture a larger share of the global market.

Infection Surveillance Solutions Market Report Scope:

The study categorizes the Infection Surveillance Solutions Market into following segments and sub-segments:

By Product & Services

• Software
  • On-premise Software
  • Web-based Software
• Up to 50 hp
  • Product Support & Maintenance Services 
  • Implementation Services
  • Training & Consulting services

By End User

• Hospitals
  • Large Hospitals
  • Medium Sized Hospitals
  • Small Hospitals
• Long-term Care Facilities
  • Nursing Homes
  • Skilled Nursing Facilities
  • Assisted- Living Facilities
• Other End Users

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia & New Zealand
  • South Korea
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa

Recent Developments

• In November 2022, Wolters Kluwer strengthened its clinical surveillance portfolio with Sentri7 Sepsis Monitor. Sentri7 Sepsis Monitor (formerly known as POC Advisor) leverages clinical natural language processing (cNLP) and advanced algorithms to surveil a hospital’s patients 24/7 to identify early signs of sepsis.
• In June 2022, Premier unveiled the PINC AI solution for long-term care (LTC) facilities. The solution provides the same level of clinical surveillance used in the acute setting.
• In January 2022, Becton, Dickinson and Company (US) collaborated Pfizer (US) and Wellcome (UK). The collaboration enabled the companies to survey existing diagnostic practices to highlight benefits and gaps in diagnostic testing in AMR stewardship to improve and further advocate for patient care, clinical practice, and healthcare economics.
• In July 2021, Baystate Health and Cerner Corporation collaborated by introducing a digital health platform to integrate care delivery and financing systems for a more consumer-focused approach to patient care.
• In February 2021, Ecolab (US) launched Hand Hygiene Compliance Measurement (HHCM) System. This system is a digitally connected technology that systematically monitors and improves hand hygiene in healthcare across Europe.

Frequently Asked Questions (FAQs):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst